Peter A. Schad, Ph.D.

Dr. Schad has over twenty years of experience in biotechnology. He has served as the Chief Scientific Officer for AlphaGene, Inc. since 1998. Previously, he was the Vice President for Bioinformatics and Biotechnology at the National Center for Genome Resources. Dr. Schad also served as a senior scientist for several biotechnology companies, including Bio-Rad Laboratories, PathoGenesis Corporation, Praxis Biologics, etc.

Dr. Schad is also an adjunct faculty member at New Mexico State University and The University of New Mexico Medical School. He has authored numerous scientific publications and book chapters and received multi-million dollar research grants from the Department of Energy and Department of Defense.